News und Analysen
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q3 2023 Earnings CallNov 02, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Cigna Group (CI) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q3 2023 Earnings CallNov 02, 2023, 8:30 a.m. ET
Operator
Source Fool.com
1 Stock Down 15% This Year to Buy and Hold Forever
The past three years have been a roller coaster for Abbott Laboratories (NYSE: ABT). The healthcare giant dealt with a slowdown in its medical device business caused by the pandemic, fluctuating
This High-Yield Dividend Stock Is a Proven Wealth Creator
Found in 1849, Pfizer (NYSE: PFE) has transformed the lives of patients and shareholders alike. The pharmaceutical titan has been one of the best-performing stocks since the end of World War II
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
Novavax (NASDAQ: NVAX) is facing some significant headwinds. Its financials aren't in great shape, and its future remains questionable. Investors have been dumping the stock in droves, and it is no
This High-Yield Dividend Stock Is a Proven Wealth Creator
Found in 1849, Pfizer (NYSE: PFE) has transformed the lives of patients and shareholders alike. The pharmaceutical titan has been one of the best-performing stocks since the end of World War II
2 Growth Stocks That Could Help Set You Up for Life
The stock market has tested even the most resilient of investors over the last two years, as bouts of volatility followed by surges across multiple sectors have become common. That's why most
2 Growth Stocks That Could Help Set You Up for Life
The stock market has tested even the most resilient of investors over the last two years, as bouts of volatility followed by surges across multiple sectors have become common. That's why most
3 Dividend Stocks That Can Power Your Portfolio for Decades
Holding some top dividend stocks in your portfolio can help you generate recurring income for years. This can bolster your savings for retirement or just give you extra money to help pay bills while
EQS-News: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
EQS-News: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years
The pharmaceutical industry has been a source of extraordinary returns for investors who have picked the right stocks. Since the end of World War II, five of the top 30 performers in the U.S. stock
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years
The pharmaceutical industry has been a source of extraordinary returns for investors who have picked the right stocks. Since the end of World War II, five of the top 30 performers in the U.S. stock
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
CRISPR Therapeutics (NASDAQ: CRSP) has reached a very important chapter in its growth story. The gene-editing specialist doesn't have products on the market right now, but that could change in just
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
CRISPR Therapeutics (NASDAQ: CRSP) has reached a very important chapter in its growth story. The gene-editing specialist doesn't have products on the market right now, but that could change in just
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
CRISPR Therapeutics (NASDAQ: CRSP) has reached a very important chapter in its growth story. The gene-editing specialist doesn't have products on the market right now, but that could change in just
Exelixis (EXEL) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q3 2023 Earnings CallNov 01, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Sarepta Therapeutics (NASDAQ: SRPT)Q3 2023 Earnings CallNov 01, 2023, 4:30 p.m. ET
Operator
Source Fool.com
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023
ECU Health and Acadia Healthcare Host Groundbreaking Ceremony for New Behavioral Health Hospital
ECU Health and Acadia Healthcare held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 144-bed behavioral health hospital in Greenville, North
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q3 2023 Earnings CallNov 01, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Pfizer Posted a Steep Loss. Is It Time to Sell?
It's been about a couple of weeks since Pfizer (NYSE: PFE) promised to make Halloween extra spooky by warning us that third-quarter results would be disappointing.
It turns out the warning was more
Pfizer Posted a Steep Loss. Is It Time to Sell?
It's been about a couple of weeks since Pfizer (NYSE: PFE) promised to make Halloween extra spooky by warning us that third-quarter results would be disappointing.
It turns out the warning was more
EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023
Why Ardelyx Stock Soared Today
Shares of Ardelyx (NASDAQ: ARDX) were up 9.5% as of 3:47 p.m. after the biotech company announced better-than-expected third-quarter 2023 results.
Ardelyx's quarterly revenue skyrocketed to $56.4